DENORA, NUNZIO
 Distribuzione geografica
Continente #
NA - Nord America 16.904
AS - Asia 7.605
EU - Europa 7.147
SA - Sud America 1.861
AF - Africa 317
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 10
Totale 33.878
Nazione #
US - Stati Uniti d'America 16.564
SG - Singapore 2.991
IT - Italia 2.566
CN - Cina 1.760
BR - Brasile 1.445
HK - Hong Kong 947
SE - Svezia 923
RU - Federazione Russa 772
DE - Germania 677
FI - Finlandia 512
VN - Vietnam 506
FR - Francia 428
GB - Regno Unito 393
UA - Ucraina 318
IN - India 252
ID - Indonesia 222
BD - Bangladesh 215
CA - Canada 168
AR - Argentina 151
IQ - Iraq 119
JP - Giappone 96
NL - Olanda 86
MX - Messico 85
TR - Turchia 84
ZA - Sudafrica 83
CI - Costa d'Avorio 69
ES - Italia 68
BE - Belgio 67
PL - Polonia 65
PK - Pakistan 63
AT - Austria 61
EC - Ecuador 59
CO - Colombia 57
VE - Venezuela 56
IE - Irlanda 53
SA - Arabia Saudita 42
CZ - Repubblica Ceca 38
MA - Marocco 36
PY - Paraguay 36
AU - Australia 30
PH - Filippine 29
UZ - Uzbekistan 29
MY - Malesia 28
JO - Giordania 25
LT - Lituania 24
CL - Cile 23
KE - Kenya 21
TH - Thailandia 21
IR - Iran 20
TN - Tunisia 20
DZ - Algeria 17
EG - Egitto 17
KR - Corea 17
JM - Giamaica 16
AZ - Azerbaigian 15
NP - Nepal 15
ET - Etiopia 13
KZ - Kazakistan 13
RO - Romania 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
PE - Perù 12
CR - Costa Rica 11
BH - Bahrain 10
OM - Oman 10
PT - Portogallo 10
BO - Bolivia 9
BY - Bielorussia 9
CH - Svizzera 9
HN - Honduras 8
LB - Libano 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
IL - Israele 7
NG - Nigeria 7
TT - Trinidad e Tobago 7
AL - Albania 6
MD - Moldavia 6
MK - Macedonia 6
NI - Nicaragua 6
QA - Qatar 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
EE - Estonia 5
GT - Guatemala 5
PA - Panama 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
DK - Danimarca 4
GD - Grenada 4
GE - Georgia 4
HR - Croazia 4
KG - Kirghizistan 4
LY - Libia 4
SV - El Salvador 4
YE - Yemen 4
DM - Dominica 3
GR - Grecia 3
KW - Kuwait 3
Totale 33.808
Città #
Ashburn 1.730
Singapore 1.621
Fairfield 1.514
Chandler 1.266
Woodbridge 1.007
San Jose 990
Hong Kong 936
Houston 837
Jacksonville 705
Milan 693
Nyköping 678
Seattle 640
Cambridge 604
Beijing 514
Wilmington 504
Ann Arbor 483
New York 382
Bari 343
Helsinki 305
Dallas 296
Los Angeles 262
Lawrence 248
Lauterbourg 247
Roxbury 243
Nanjing 218
Rome 205
Boardman 186
Brooklyn 163
Des Moines 147
Council Bluffs 141
Ho Chi Minh City 137
São Paulo 135
Princeton 134
Hanoi 127
Santa Clara 124
Jakarta 119
Munich 112
Columbus 96
Chicago 95
London 86
Buffalo 80
Grottaglie 80
Frankfurt am Main 75
Falkenstein 70
Abidjan 69
San Diego 68
Brussels 66
Baghdad 63
Inglewood 63
Tokyo 63
Dong Ket 59
Figino 56
Bitonto 54
Warsaw 54
Hebei 53
Shenyang 53
Dublin 50
Jiaxing 49
Nuremberg 49
San Francisco 49
Denver 47
Montreal 47
Nanchang 46
Turin 46
Rio de Janeiro 44
Johannesburg 43
Moscow 43
Orem 43
Turku 43
Tianjin 42
Paris 41
Atlanta 40
Bitetto 40
Amsterdam 39
Falls Church 39
Toronto 38
Belo Horizonte 35
Guangzhou 34
The Dalles 34
Vienna 34
Washington 33
Chennai 32
Napoli 32
Stockholm 31
Boston 29
Mexico City 29
Shanghai 29
Hangzhou 28
Elk Grove Village 27
Guayaquil 27
Mumbai 26
Phoenix 26
Salt Lake City 26
Wuhan 26
Naples 25
Tashkent 25
Changsha 24
Dearborn 24
Asunción 23
Haiphong 23
Totale 21.859
Nome #
S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery 315
Boric Acid, a Lewis Acid With Unique and Unusual Properties: Formulation Implications 294
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 290
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base 267
Grape seed extracts modify the outcome of oxaliplatin in colon cancer cells by interfering with cellular mechanisms of drug cytotoxicity 262
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 258
Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates 252
Lipid-based systems loaded with PbS nanocrystals: near infrared emitting trackable nanovectors 246
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 245
Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery 243
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 228
NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging 218
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. 216
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 216
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 213
A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells 204
Exploring Basic Tail Modifications of Coumarin-based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-soluble, Brain-permeant Neuroprotective Multitarget Agents 199
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors 196
Principi di calcolo farmaceutico 195
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 195
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 195
Antitumor Potential of Conjugable Valinomycins Bearing Hydroxyl Sites: In Vitro Studies 190
Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. 190
Delivery of proapoptotic agents in glioma cell lines by TSPO ligand–dextran nanogels 190
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration 190
Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases 189
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 188
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 188
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders 186
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 185
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml 185
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 183
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 181
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 181
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3 178
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 177
FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation 172
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 172
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. 171
Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging 171
Contact allergy to electrocardiogram electrodes caused by acrylic acid without sensitivity to methacrylates and ethyl cyanoacrylate 171
2-Phenyl-imidazo[1,2-a]pyridine compounds containing hydrophilic groups as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity and electrophysiological studies 169
One pot environmental friendly synthesis of Gold Nanoparticles using Punica Granatum Juice: a novel antioxidant agent for future dermatological and cosmetic applications. 169
N-benzyl-2-(6,8-dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3yl)-N(6-(7-nitrobenzo[c][1,2,5]oxadiazol-4-ylamino)hexyl)acetamide as a new fluorescentprobe for peripheral benzodiazepine receptor and microglialcell visualization 168
TSPO ligand-methotrexate prodrug conjugates: Design, synthesis, and biological evaluation 168
Effect Of Diazoxide on Friedreich Ataxia Models 168
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 166
Automated identification of structurally heterogeneous and patentable antiproliferative hits as potential tubulin inhibitors 166
The Complexity of the Blood-Brain Barrier and the Concept of Age-Related Brain Targeting: Challenges and Potential of Novel Solid Lipid-Based Formulations 166
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 165
Some Preformulation Studies of Pyruvic Acid and Other α-Keto Carboxylic Acids in Aqueous Solution: Pharmaceutical Formulation Implications for These Peroxide Scavengers 165
Novel chemotypes targeting tubulin at the Colchicine binding site and unbiasing P-glycoprotein 164
Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs. 163
Synthesis and Biological Evaluation of a Valinomycin Analog Bearing a Pentafluorophenyl Active Ester Moiety 163
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 162
Searching for Multitargeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE−MAO B Inhibitors through the Decoration of 2H-Chromen-2-one Structural Motif 160
Anticoagulant activity of new glycoconjugated inhibitors Of factor Xa and thrombin 158
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione 157
Bortezomib Aqueous Solubility in the Presence and Absence of D-Mannitol: A Clarification With Formulation Implications 156
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate 155
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 155
New biodegradable hydrogels based on inulin and α,β-polyaspartylhydrazide designed for colonic drug delivery: in vitro release of glutathione and oxytocin 154
Biotin-decorated silica coated PbS nanocrystals emitting in the second biological near infrared window for bioimaging 154
b-Cyclodextrin in personal care formulation: role on the complexation of malodors causing molecules 153
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 152
Enzymatic Resolution of α-Methyleneparaconic Acids and Evaluation of their Biological Activity 151
Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation 149
Assessment of TSPO in a rat experimental autoimmune myocarditis model: A comparison study between [18F] fluoromethyl-PBR28 and [18F]CB251 149
Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [11C]CB184 and [11C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [11C](R)-PK11195 146
Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier 145
Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery 145
Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration 144
Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms 144
A rapid screening tool for estimating the potential of 2-hydroxypropyl-beta-cyclodextrin complexation for solubilization purposes 143
AZEPINO [4,3-b]INDOLE DERIVATIVES AS SELECTIVE INHIBITORS OF HUMAN BUTYRYLCHOLINESTERASE WITH PROTECTIVE EFFECTS AGAINST NMDA-INDUCED NEUROTOXICITY 142
Chiral Separation, X-ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site AChE Inhibitor 142
B-CYCLODEXTRIN IN PERSONAL CARE FORMULATION: ROLE ON THE COMPLEXATION OF MALODORS CAUSING MOLECULES 140
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position 140
Site-dependent biological activity of valinomycin analogs bearing derivatizable hydroxyl sites 139
Antiplatelet 2-Hydroxy Thienopyridine Ester Derivatives for the Reduction of Thrombotic Cardiovascular Events 139
Direct cyclodextrin based powder extrusion 3D printing of budesonide loaded mini-tablets for the treatment of eosinophilic colitis in paediatric patients 138
Novel L-dopa and dopamine prodrugs containing a 2-phenyl-imidazopyridine moiety 138
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 137
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 135
An updated view of translocator protein (TSPO) 135
CAT microscopy: a novel tool for 3D cell investigation 134
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor 134
Translocator Protein Ligand-PLGA conjugates nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells 133
Nanoformulations for drug delivery: safety, toxicity, and efficacy 133
Comparative effect of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 132
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 132
Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy 131
Biological Evaluation Of Some Peripheral Benzodiazepine Receptor Ligand Cytarabine Conjugates For Selective Delivery To Human Lymphoma 131
Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery 130
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 129
Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery 128
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer 128
TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging 127
From oil to microparticulate by prilling technique: Production of polynucleate alginate beads loading Serenoa Repens oil as intestinal delivery systems 127
beta-Cyclodextrin in personal care formulation: role on the complexation of malodours causing molecules 125
Totale 17.256
Categoria #
all - tutte 142.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.156 120 219 34 40 85 181 95 82 202 272 291 535
2022/20233.305 491 405 220 281 385 420 57 382 485 43 92 44
2023/20241.422 88 203 88 89 161 389 70 84 25 31 31 163
2024/20255.975 231 102 412 205 218 518 752 534 244 359 848 1.552
2025/202612.455 1.600 572 805 1.250 1.275 652 1.452 414 1.428 1.209 475 1.323
2026/2027508 508 0 0 0 0 0 0 0 0 0 0 0
Totale 34.829